|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2009-2-16
|
|
pubmed:abstractText |
Hypothalamic-chiasmatic gliomas (HCG) account for up to 20% of tumors in patients under the age of 3 years. While most children respond to chemotherapy, alternative treatment approaches are needed for those with progressive disease refractory to chemotherapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1545-5017
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2008 Wiley-Liss, Inc.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
52
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
476-80
|
|
pubmed:meshHeading |
pubmed-meshheading:19061223-Antineoplastic Agents,
pubmed-meshheading:19061223-Child, Preschool,
pubmed-meshheading:19061223-Female,
pubmed-meshheading:19061223-Glioma,
pubmed-meshheading:19061223-Humans,
pubmed-meshheading:19061223-Hypothalamic Neoplasms,
pubmed-meshheading:19061223-Immunohistochemistry,
pubmed-meshheading:19061223-Infant,
pubmed-meshheading:19061223-Male,
pubmed-meshheading:19061223-Neoplasm Recurrence, Local,
pubmed-meshheading:19061223-Optic Chiasm,
pubmed-meshheading:19061223-Optic Nerve Glioma,
pubmed-meshheading:19061223-Piperazines,
pubmed-meshheading:19061223-Pyrimidines,
pubmed-meshheading:19061223-Treatment Outcome
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Tumor stabilization under treatment with imatinib in progressive hypothalamic-chiasmatic glioma.
|
|
pubmed:affiliation |
Department of Pediatrics, Medical University of Vienna, Vienna, Austria.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
